Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001161697-15-000349
Filing Date
2015-08-14
Accepted
2015-08-14 16:11:52
Documents
12
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q QUARTERLY REPORT FOR 06-30-2015 form_10-q.htm 10-Q 407791
2 RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER ex_31-1.htm EX-31 10239
3 RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATIONS OF PRINCIPAL FINANCIAL OFFICER ex_31-2.htm EX-31 10249
4 RULE 1350 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex_32-1.htm EX-32 3581
5 RULE 1350 CERTIFICATIONS OF CHIEF FINANCIAL OFFICER ex_32-2.htm EX-32 3591
6 PRESS RELEASE ex_99-1.htm EX-99 9958
  Complete submission text file 0001161697-15-000349.txt   3492040

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE cik1537917-20150630.xml EX-101.INS 389061
8 XBRL SCHEMA FILE cik1537917-20150630.xsd EX-101.SCH 38038
9 XBRL CALCULATION FILE cik1537917-20150630_cal.xml EX-101.CAL 48346
10 XBRL DEFINITION FILE cik1537917-20150630_def.xml EX-101.DEF 142267
11 XBRL LABEL FILE cik1537917-20150630_lab.xml EX-101.LAB 761144
12 XBRL PRESENTATION FILE cik1537917-20150630_pre.xml EX-101.PRE 333091
Mailing Address 48 WALL STREET - SUITE 1100 NEW YORK NY 10005
Business Address 48 WALL STREET - SUITE 1100 NEW YORK NY 10005 646-205-1603
TYME TECHNOLOGIES, INC. (Filer) CIK: 0001537917 (see all company filings)

EIN.: 453864597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-179311 | Film No.: 151055918
SIC: 2834 Pharmaceutical Preparations